logo

For the Inventor, By the Inventor

Blacksburg, VA, United States of America

Intrexon Corporation


USPTO Granted Patents = 121



Trademarks = 10

Forward Citations = 929

Loading Chart...
Loading Chart...

82 inventors (with patents filed for the assignee):

goldMedal Thomas David Reed (41 out of 47 patents)

silverMedal Robert Eugene Hormann (35 out of 44 patents)

bronzeMedal Subba Reddy Palli (30 out of 36 patents)

4.  Dean Ervin Cress (17 out of 21 patents)

5.  Orestes Chortyk (14 out of 14 patents)

6.  Colin M Tice (14 out of 68 patents)

7.  Amy Hobbs Atzel (12 out of 13 patents)

8.  Glenn Richard Carlson (10 out of 19 patents)

9.  Mohan Basavaraju Kumar (8 out of 10 patents)

10.  Tarlochan Singh Dhadialla (8 out of 11 patents)

11.  Inna Shulman (7 out of 21 patents)

12.  David W Potter (7 out of 8 patents)

13.  Andrew Meyer (7 out of 7 patents)

14.  Thomas R Opie (7 out of 10 patents)

15.  Robert Beech (6 out of 8 patents)


Core Competencies:
Boron-Containing Diacylhydrazines
Serine Recombinases
Chiral Diacylhydrazine Ligands
Therapeutic Gene-Switch Constructs
Engineered Cells
Ecdysone Receptor Complex
Biological Production
Immunomodulators
Nuclear Receptor-Based Systems
Dynamic Vector Assembly
Polynucleotides Encoding Ligands

121 patents:

1. 10851119 - Boron-containing diacylhydrazines (2020-12-01),
2. 10648003 - Site-specific serine recombinases and methods of their use (2020-05-12),
3. 10633361 - Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex (2020-04-28),
4. 10584351 - Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof (2020-03-10),
5. 10570158 - Boron-containing diacylhydrazine compounds (2020-02-25),
6. 10501405 - Crystalline diacylhydrazine and the use thereof (2019-12-10),
7. 10464951 - Boron-containing diacylhydrazines (2019-11-05),
8. 10314926 - Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof (2019-06-11),
9. 10190124 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2019-01-29),
10. 10131916 - Regulatory element for heterologous protein production in the fruiting body of filamentous fungi (2018-11-20),
11. 10087231 - Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system (2018-10-02),
12. 10081817 - Site-specific serine recombinases and methods of their use (2018-09-25),
13. 10046049 - Engineered cells expressing multiple immunomodulators and uses thereof (2018-08-14),
14. 10036026 - Methods for dynamic vector assembly of DNA cloning vector plasmids (2018-07-31),
15. 9944659 - Boron-containing diacylhydrazine compounds (2018-04-17),
Intrexon Corporation is a biotechnology company that designs and engineers living systems to address the world's greatest challenges. With proprietary synthetic biology technologies and expertise, Intrexon aims to create gene-based solutions in healthcare, agriculture, energy, and environmental sectors. Their innovations include the development of genetically modified organisms, biotherapeutics production, and insect control strategies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

...
121 Patents

#2 in Blacksburg, VA

#56 in Virginia

#3,063 in US

#6,401 in the World

...
Blacksburg, VA, United States of America

Intrexon Corporation

Forward Citations = 929

82 inventors:

goldMedal Thomas David Reed (41 out of 47 patents)

silverMedal Robert Eugene Hormann (35 out of 44 patents)

bronzeMedal Subba Reddy Palli (30 out of 36 patents)

4.  Dean Ervin Cress (17 out of 21 patents)

5.  Orestes Chortyk (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…